Obtaining Consumer Comments on Submission for Subsidisation of FreeStyle Libre Flash Glucose Monitoring System

Closed 17 Jul 2017

Opened 20 Jun 2017

Overview

The National Diabetes Services Scheme (NDSS) was established in 1987 to provide subsidised access to products and services required for self-management of diabetes.

The Scheme currently provides subsidised syringes and needles, blood glucose test strips, urine ketone test strips and insulin pump consumables to people with diabetes. 

The Department of Health is conducting an evaluation of the FreeStyle Libre Flash Glucose Monitoring (FGM) product to consider its suitability for subsidisation under the Scheme.

The cost-effectiveness evaluation will follow a methodology similar to that used by the Pharmaceutical  Benefits Advisory Committee (PBAC).

The Assessment panel will take into account the clinical effectiveness, safety and cost effectiveness (value for money) of the FreeStyle Libre product compared to an appropriate comparator. 

As part of their submission, the sponsor provided the Department with detailed clinical and economic data in support of the product.  For more detail about the product refer to https://www.freestylelibre.com.au/

The Assessment panel is accepting public submissions from stakeholders.  If you would like to make a submission, you can complete this survey online or by downloading the form through the link at the bottom of this page and mailing a hardcopy to:

Diabetes Products Section
Pharmaceutical Access Branch
Department of Health
MDP 1011, GPO Box 9848
Canberra  ACT  2601

Your completed form must be received no later than 17 July 2017.  All comments received will be considered.

If you have problems submitting this form please contact us by email at: ndss.products@health.gov.au

What Happens Next

The Advisory Group will consider submissions made by the public and will make a recommendation about the product.

Audiences

  • Anyone from any background

Interests

  • Health technology